Showing 1 - 8 results of 8 for search 'Lorey K Smith', query time: 0.04s Refine Results
  1. 1
    Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies

    Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies by Arwa Alkaraki, Grant A. McArthur, Karen E. Sheppard, Lorey K. Smith

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?

    Obesity and the Impact on Cutaneous Melanoma: Friend or Foe? by Lorey K. Smith, Shaghayegh Arabi, Emily J. Lelliott, Grant A. McArthur, Karen E. Sheppard

    Published 2020-06-01
    Get full text
    Article
  3. 3
    The therapeutic potential of targeting minimal residual disease in melanoma

    The therapeutic potential of targeting minimal residual disease in melanoma by Riyaben P Patel, Pretashini M Somasundram, Lorey K. Smith, Karen E. Sheppard, Grant A. McArthur

    Published 2023-03-01
    Get full text
    Article
  4. 4
    CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAF<sup>V600</sup> Melanoma via a p53 Dependent Pathway

    CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAF<sup>V600</sup> Melanoma via a p53 Dependent Pathway by Nancy T. Santiappillai, Shatha Abuhammad, Alison Slater, Laura Kirby, Grant A. McArthur, Karen E. Sheppard, Lorey K. Smith

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland.

    Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. by Nathan J Godde, Julie M Sheridan, Lorey K Smith, Helen B Pearson, Kara L Britt, Ryan C Galea, Laura L Yates, Jane E Visvader, Patrick O Humbert

    Published 2014-05-01
    Get full text
    Article
  6. 6
    Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma

    Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma by Peter Kar Han Lau, Carleen Cullinane, Susan Jackson, Rachael Walker, Lorey K. Smith, Alison Slater, Laura Kirby, Riyaben P. Patel, Bianca von Scheidt, Clare Y. Slaney, Grant A. McArthur, Karen E. Sheppard

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia

    Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia by Joan So, Alexander C Lewis, Lorey K Smith, Kym Stanley, Rheana Franich, David Yoannidis, Lizzy Pijpers, Pilar Dominguez, Simon J Hogg, Stephin J Vervoort, Fiona C Brown, Ricky W Johnstone, Gabrielle McDonald, Danielle B Ulanet, Josh Murtie, Emily Gruber, Lev M Kats

    Published 2022-07-01
    Get full text
    Article
  8. 8
    Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer

    Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer by Kathleen I. Pishas, Karla J. Cowley, Ahwan Pandey, Therese Hoang, Jessica A. Beach, Jennii Luu, Robert Vary, Lorey K. Smith, Carolyn E. Shembrey, Nineveh Rashoo, Madelynne O. White, Kaylene J. Simpson, Andrea Bild, Jason I. Griffiths, Dane Cheasley, Ian Campbell, David D. L. Bowtell, Elizabeth L. Christie

    Published 2021-11-01
    Get full text
    Article

Search Tools: